KEVIN VERDE: Open Payments
NPI 1801344692 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$793 in 21 payments from 8 companies in 2025. Trend: 2023 $223 · 2024 $577 · 2025 $793
Food & beverage: $793
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $361 |
| Exact Sciences Corporation | 6 | $139 |
| Amgen Inc. | 2 | $113 |
| Novo Nordisk Inc | 1 | $92 |
| Gilead Sciences, Inc. | 1 | $32 |
| Abbott Laboratories | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: AIRSUPRA, The Cologuard Plus Collection Kit, REPATHA, Wegovy, BREZTRI, FREESTYLE LIBRE, JARDIANCE, MOUNJARO.
Industry payments across FL — which companies pay providers there.
